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Conditional ablation of myeloid 
TNF increases lesion volume 
after experimental stroke in 
mice, possibly via altered ERK1/2 
signaling
Bettina Hjelm Clausen1, Matilda Degn2, Mithula Sivasaravanaparan1, Torben Fogtmann1, 
Maria Gammelstrup Andersen1, Michelle D. Trojanowsky3, Han Gao3, Svend Hvidsten4, 
Christina Baun4, Tomas Deierborg5, Bente Finsen1, Bjarne Winther Kristensen6,7, 
Sara Thornby Bak1, Morten Meyer1, Jae Lee3, Sergei A. Nedospasov8, Roberta Brambilla3  
& Kate Lykke Lambertsen1,9
Microglia are activated following cerebral ischemia and increase their production of the neuro- and 
immunomodulatory cytokine tumor necrosis factor (TNF). To address the function of TNF from this 
cellular source in focal cerebral ischemia we used TNF conditional knock out mice (LysMcreTNFfl/fl) 
in which the TNF gene was deleted in cells of the myeloid lineage, including microglia. The deletion 
reduced secreted TNF levels in lipopolysaccharide-stimulated cultured primary microglia by ~93%. 
Furthermore, phosphorylated-ERK/ERK ratios were significantly decreased in naïve LysMcreTNFfl/fl  
mice demonstrating altered ERK signal transduction. Micro-PET using 18[F]-fluorodeoxyglucose 
immediately after focal cerebral ischemia showed increased glucose uptake in LysMcreTNFfl/fl mice, 
representing significant metabolic changes, that translated into increased infarct volumes at 24 hours 
and 5 days compared to littermates (TNFfl/fl). In naïve LysMcreTNFfl/fl mice cytokine levels were low 
and comparable to littermates. At 6 hours, TNF producing microglia were reduced by 56% in the 
ischemic cortex in LysMcreTNFfl/fl mice compared to littermate mice, whereas no TNF+ leukocytes 
were detected. At 24 hours, pro-inflammatory cytokine (TNF, IL-1β, IL-6, IL-5 and CXCL1) levels were 
significantly lower in LysMcreTNFfl/fl mice, despite comparable infiltrating leukocyte populations. Our 
results identify microglial TNF as beneficial and neuroprotective in the acute phase and as a modulator 
of neuroinflammation at later time points after experimental ischemia, which may contribute to 
regenerative recovery.
Microglial activation constitutes a major defense mechanism against ischemic brain injury, with dual effects link-
ing microglial activation to both neurotoxic and neuroprotective effects in the brain1,2. When activated, microglial 
cells become the main producers of proinflammatory cytokines, such as tumor necrosis factor (TNF), which is 
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crucial in detemining neuronal survival and orchestrating neuroinflammation following stroke2–5. TNF exists 
as both transmembrane TNF (mTNF) and soluble TNF (solTNF), which is released into the extracellular space 
after cleavage of mTNF by the metalloproteinase TNFα converting enzyme (TACE/ADAM17)5. Both forms are 
biologically active but have distinct functions in the CNS5–9.
The effect of TNF is mediated by two cell surface receptors, TNF-R1 and TNF-R2. These receptors may 
feed into diverse signaling pathways according to differences in their intracellular domains. A death domain in 
TNF-R1, not present in TNF-R2, can lead to apoptotic cell death, although most cell types are protected due to 
expression of anti-apoptotic proteins. Alternative pathways of TNF-R1 signaling involve activation of the ERK1/2 
MAP kinases and NF-κ B activation10,11 serving neuroprotective functions. Similarly, TNFR2 receptor signaling 
through the NF-κ B pathway is primarily associated with neuroprotection and axonal preservation6,9,12,13.
In experimental stroke, genetic ablation of solTNF, with sustained mTNF expression, is associated with 
reduced infarct volume, improved functional outcome and an altered pro-inflammatory environment5, just as 
the systemically administered anti-solTNF compound XPro1595 improves functional outcome after experimen-
tal stroke3. On the other hand, conventional TNF knock out (TNF−/−) mice display increased infarct volumes 
and worse functional outcome after experimental stroke4. The neuroprotective effect of TNF is suggested to be 
mediated through TNF-R1, findings which are in line with studies showing increased infarct volumes in TNF-R1 
deficient mice4,14,15 and that ischemic tolerance is mediated through upregulation of TNF-R116.
Given the contribution of microglia/macrophages to the pathophysiology of stroke, in the present study, we 
investigated the effect of TNF ablation specifically in myeloid cells on neuroprotection and functional outcome 
after focal cerebral ischemia. We demonstrate that LysMcreTNFfl/fl mice lacking TNF in myeloid cells display 
phenotypical alterations in microglia, including altered ERK signaling. In addition, FDG uptake in the ischemic 
brain during the acute phase after ischemia (1–3 hours) is increased in LysMcreTNFfl/fl mice resulting in increased 
infarct volumes 24 hours and 5 days after focal cerebral ischemia. The relevance of the present study was under-
lined by investigating glial activation, TNF and TNF receptor expression in human autopsy material from stroke 
patients. This may have significant implications for the development of future neuroprotective treatment strate-
gies in the acute phase after stroke, as modulating the microglial TNF response acutely can provide a viable option 
to boost neuroprotection.
Results
Characterization of LysMcreTNFfl/fl mice with conditional ablation of TNF in myeloid cells. In 
order to assess the effect of genetic ablation of TNF in myeloid cells, we first characterized LysMcreTNFfl/fl mice 
under naïve conditions. LysMcreTNFfl/fl mice were comparable to TNFfl/fl mice displaying normal cerebrovas-
cular anatomy at the level of the circle of Willis (Fig. 1a), similar cortical volumes (Fig. 1b), as well as body 
composition (Suppl. Table 1). Furthermore, conditional TNF ablation resulted in no abnormal locomotor func-
tion, as previously observed in conventional TNF−/− mice5, when subjected to the rotarod and open field test 
(Suppl. Table 1). We found LysMcreTNFfl/fl mice to have normal neuromuscular function, balance, motor coor-
dination and spontaneous activity (Suppl. Table 1), just as anxiety-related behaviors (grooming, fecal droppings, 
latency to rear and center/peri-meter ratio) were not altered compared to TNFfl/fl mice (Suppl. Table 1). When 
testing for spontanoeus alternation behavior (SAB) and working memory, we found no difference in SAB % but 
significantly fewer Y-maze entries in LysMcreTNFfl/fl mice compared to controls (Suppl. Table 1).
Since conventional TNF−/− mice are known to display reduced numbers of microglia4, we next quantified 
microglia by flow cytometry using CD45 levels to distinguish CD45dim microglia from infiltrating CD45high leu-
kocytes (Fig. 1c–e). We found comparable microglial numbers (Fig. 1d) and percentages (Fig. 1e) between TNFfl/fl 
and LysMcreTNFfl/fl mice. However, mean fluorescence intensity (MFI) revealed higher CD11b (Suppl. Fig. 1a) 
and lower CD45 (Suppl. Fig. 1b) expression levels on microglia in naïve LysMcreTNFfl/fl compared to TNFfl/fl 
mice. Analysis of whole blood showed comparable numbers of monocytes and T cells, but fewer Gr1+ granulo-
cytes in LysMcreTNFfl/fl compared to TNFfl/fl mice (Suppl. Fig. 1c,d). In the spleen, monocytes, granulocytes and 
T cells were comparable between the two genotypes (Suppl. Fig. 1c,d).
We addressed recombination efficiency in microglial cells by crossing MLys1cre mice with Rosa26-tdTomato 
reporter mice and quantified the number of cortical tdTomato+ cells in naïve conditions by cell counting and flow 
cytometry (Suppl. Fig. 2). Under naïve conditions, we found 12% (cell counting) to 20% (flow cytometry) of all 
CD11b+ microglial cells to be tdTomato+. No tdTomato+ cells co-labelled with GFAP or Olig2, but a small pro-
portion of neurons were tdTomato+ (5%). Since microglia increase LysM expression under ischemic and inflam-
matory conditions17–19, we next tested the cre-mediated reporter gene activation under inflammatory conditions 
using cultured microglia harvested from TNFfl/fl and LysMcreTNFfl/fl mice (Fig. 1f,g). Following LPS-stimulation, 
we found that microglia from LysMcreTNFfl/fl mice showed a ∼ 93% decrease in TNF production as compared 
to microglia from TNFfl/fl mice (Fig. 1g). Astrocytes stimulated with either IL-1β or TNF secreted comparable 
amounts of TNF, with no difference between TNFfl/fl and LysMcreTNFfl/fl mice (Fig. 1h), collectively demonstrat-
ing a successful TNF ablation in activated microglia from LysMcreTNFfl/fl mice.
Altogether, these data demonstrate a successful TNF ablation in activated microglia and support the use of 
LysMcreTNFfl/fl mice as a suitable model to study microglial/myeloid TNF function in vivo.
Conditional ablation of myeloid TNF increases infarct volume after focal cerebral ischemia. 
The effect of myeloid TNF ablation in cerebral ischemia was assessed by comparing infarct volumes in TNFfl/fl to 
LysMcreTNFfl/fl mice after pMCAO (Fig. 2a,b). In LysMcreTNFfl/fl mice infarct volumes were significantly larger 
than in TNFfl/fl mice at 24 hours (30%) (Fig. 2a) and at 5 days (45%) (Fig. 2b) after pMCAO. Histological analysis 
showed that infarcts were evenly distributed along the rostrocaudal axis in both genotypes (Fig. 2a,b).
To assess functional outcome, we subjected the mice to a battery of behavioral tests, but found no locomotor or 
sensory-motor differences between TNFfl/fl and LysMcreTNFfl/fl mice 2 and 5 days after pMCAO (Suppl. Table 2). 
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Rung walk analysis of both front and hinds paws (total slips) on day 2 after pMCAO showed clear asymmetry 
between the left (L) and right (R) side (Fig. 2c), as did grip strength of the front paws 5 days after pMCAO 
(Fig. 2d) in both TNFfl/fl and LysMcreTNFfl/fl mice. Both groups of mice performed similarly on the rotarod 5 
days after pMCAO (Fig. 2e). In the open field test 2 days after pMCAO, we found no difference between TNFfl/fl 
and LysMcreTNFfl/fl mice in total distance traveled, speed, zone changes and number of rearings (Suppl. Table 2). 
Also no change in anxiety-related behaviors, such as center/perimeter ratio, latency to rear and number of drop-
pings were found, except for grooming behavior, which was significantly increased in TNFfl/fl mice after pMCAO 
(Suppl. Table 2). The lack of differences in functional outcome most likely reflects the large cortical infarcts in 
both genotypes.
FDG uptake is increased in the acute phase after pMCAO in LysMcreTNFfl/fl compared to TNFfl/fl 
mice. To assess ischemia-dependent changes in glucose metabolism immediately after pMCAO (1–3 hours), 
we performed 18[F]-FDG-PET imaging (Fig. 3a). Dynamic scans revealed an early (< 10 min) reduction in FDG 
uptake in the ipsilateral cortex compared to the contralateral in both genotypes, most likely as a result of ceased 
blood flow to the lesion site (Fig. 3b). Ten to 15 min after injection, FDG uptake switched and was increased in the 
ipsilateral side compared to the contralateral side in both TNFfl/fl and LysMcreTNFfl/fl mice. However, beginning 
approximately 35 min post-injection, ipsilateral FDG uptake was significantly higher in the ipsilateral hemisphere 
in LysMcreTNFfl/fl compared to TNFfl/fl controls (Fig. 3b), demonstrating an increased glucose demand in the 
ipsilateral hemisphere after pMCAO. This is consistent with the presence of larger infarcts in LysMcreTNFfl/fl mice 
where cells increased glucose uptake after stroke onset.
Figure 1. Characterization of LysMcreTNFfl/fl mice. (a) Photomicrographs of the posterior part of the circle 
of Willis in TNFfl/fl and LysMcreTNFfl/fl mice showing similar vascular anatomy of the posterior part of the circle 
of Willis after carbon ink perfusion. There were no differences in the mean posterior communicating artery 
scores between TNFfl/fl and LysMcreTNFfl/fl mice based on carbon ink labeling (P = 0.42, n = 8–10/group, t-test). 
Abbreviations: BA, basilar artery; PCA, posterior cerebral artery; PCOM, posterior communicating artery; 
SCA, superior cerebellar artery. (b) Neocortical volumes were comparable in TNFfl/fl and LysMcreTNFfl/fl mice 
(n = 4–5/group, t-test). (c) Gating strategy for microglia in the cortex of naïve TNFfl/fl and LysMcreTNFfl/fl mice. 
Gate was defined to include only live cells in the further analysis. The microglial population was identified as 
CD11b+CD45dim cells. (d,e) Flow cytometric analysis showed equivalent numbers (d) and percentages (e) of 
microglia in the cortices of naïve TNFfl/fl and LysMcreTNFfl/fl mice (n = 6–9/group, t-test). (f–h) Stimulation of 
TNF production in primary microglial cultures treated with LPS showed that only TNFfl/fl microglia produced a 
robust TNF response upon stimulation, whereas TNF levels remained at baseline levels in LysMcreTNFfl/fl  
microglia (n = 12–17 wells/experimental group, 2 independent experiments, t-test) (g). In contrast, primary 
astrocytes from both TNFfl/fl and LysMcreTNFfl/fl mice produced a robust TNF response upon stimulation with 
either IL-1β or TNF (n = 6 wells/experimental group, 2 independent experiments) (h). All data are presented as 
mean ± SEM.
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VOI-based analysis of 18[F]-FDG-PET imaging comparing the normalized rate constants (Ki, influx rate; K1, 
rate blood to tissue; k2, rate tissue to blood; k3, binding rate) revealed significant differences between TNFfl/fl 
and LysMcreTNFfl/fl mice (Table 1). The increase in Ki corresponded to a 37% elevation in glucose uptake in 
LysMcreTNFfl/fl compared to TNFfl/fl mice. A second scan 24 hours later revealed a lower ipsilateral FDG uptake 
in both groups (Fig. 3c) due to loss of cells in the ischemic region. However, there was no significant difference in 
the uptake pattern 24 hours after pMCAO, as demonstrated by previous findings of a fully mature infarct at this 
time point20.
Ablation of myeloid TNF alters MAPK protein expression in naïve conditions but not after 
pMCAO. Since TNF-dependent MAPK signaling has been associated with neuroprotection under ischemic 
conditions21, we evaluated whether the increase of infarct volumes in LysMcreTNFfl/fl mice could be associated 
with alterations in MAPK signaling. Interestingly, we found pERK1/ERK1 and pERK2/ERK2 ratios to be signifi-
cantly decreased in LysMcreTNFfl/fl mice compared to TNFfl/fl mice under naïve conditions (60% and 75%, respec-
tively) (Fig. 4a), suggesting that ERK signaling is intrinsically downregulated in LysMcreTNFfl/fl mice, which 
could impair ERK-dependent neuroprotective signaling acutely (within the first 6 hours) after pMCAO. Despite 
tendencies, pERK1/ERK1 and pERK2/Erk2 ratios were not different between TNFfl/fl and LysMcreTNFfl/fl mice 
6 hours after pMCAO (Fig. 4a). No differences were found in p-p54/p54, p-p46/p46 (SAPK/JNK) (Fig. 4b), or 
p-p38/p38 (Fig. 4c) ratios in naïve and ischemic conditions.
Ablation of myeloid TNF reduces the ischemic-induced expression of pro-inflammatory 
cytokines and chemokines 24 hours after pMCAO. To assess changes in the inflammatory response 
between TNFfl/fl and LysMcreTNFfl/fl mice, we assessed cytokine, chemokine, and TNFR protein expression in 
Figure 2. Infarct volumes are increased in LysMcreTNFfl/fl mice. (a,b) Toluidine blue staining of brain 
sections from TNFfl/fl and LysMcreTNFfl/fl mice 24 hours (a) and 5 days (b) after focal cerebral ischemia. 
Abbreviations: Ctx, cortex; IF, infarct; Str, striatum. Scale bar = 500 μ m. Estimation of cortical infarct volumes 
showed that LysMcreTNFfl/fl mice developed significantly larger infarcts compared with TNFfl/fl both at 24 hours 
(a), (left graph) and 5 days (b), (left graph) (n = 8–12/group and n = 15–25, respectively, t-test). Analysis of the 
rostrocaudal distribution of the infarct areas 24 hours (a), (right graph) and 5 days (b), (right graph) after focal 
cerebral ischemia showed that TNFfl/fl and LysMcreTNFfl/fl mice displayed similar rostrocaudal distribution of 
the infarcts. (c) Rung walk analysis at day 2 showed that both TNFfl/fl and LysMcreTNFfl/fl mice presented with 
significantly more total slips on their right limbs compared to their left limbs (n = 6–13/group, paired t-test).  
(d) Grip strength analysis at day 5 showed front paw asymmetry (Δ grip strength) in both TNFfl/fl  
and LysMcreTNFfl/fl mice (n = 5–6/group, paired t-test). (e) Rotarod performance at day 5 was comparable 
between TNFfl/fl and LysMcreTNFfl/fl mice (n = 10–14/group). * P ≤ 0.05, * * P ≤ 0.01. All data are presented as 
mean ± SEM.
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naïve conditions and after pMCAO by multiplex analysis (Fig. 5a–c and Suppl. Table 3). No differences in protein 
expression were found in naïve conditions except for TNFR1, which was significantly increased in LysMcreTNFfl/fl 
compared to TNFfl/fl mice (Fig. 5b). Similarly, 6 hours and 5 days after pMCAO no differences in protein expres-
sion were detected (Suppl. Table 3). At 24 hours after pMCAO, however, TNF, IL-1β , IL-6, IL-5 and CXCL1 were 
significantly reduced in LysMcreTNFfl/fl mice compared to TNFfl/fl controls, while IL-2, IL-4, IL-10, IFNγ or 
IL-12p70 did not change (Fig. 5a). Cytokine levels were also measured in the plasma in naïve and ischemic con-
ditions but no changes were found at any time point between TNFfl/fl and LysMcreTNFfl/fl mice (Suppl. Fig. 3).
Figure 3. Dynamic PET analysis of LysMcreTNFfl/fl and TNFfl/fl mice in the acute phase after pMCAO. 
(a) Coregistered computed tomographic (CT) images and position emission tomographic (PET) images 
from TNFfl/fl and LysMcreTNFfl/fl mice with [18]F-2-fluoro-2-deoxy-D-glucose (FDG) injected 30 min after 
pMCAO. (b) Dynamic uptake curves from a cortical region in the contralateral hemisphere (dashed lines) 
and ischemic region (solid lines). The ischemic region was defined from the last PET frame showing elevated 
FDG uptake. FDG uptake in the ischemic region at 67.5–82.5 min was significantly higher than that in the 
contralateral hemisphere in LysMcreTNFfl/fl mice and at 37.5–85.5 min in TNFfl/fl mice (* P ≤ 0.05; * * P ≤ 0.01; 
* * * P ≤ 0.001). FDG uptake was also significantly increased at 37.5–85.5 min in the ipsilateral hemisphere in 
LysMcreTNFfl/fl mice compared to the ipsilateral hemisphere in TNFfl/fl mice (#P ≤ 0.05) (n = 4–5/group, Two-
way ANOVA followed by Bonferroni’s corrected multiple t-test). (c) Coregistered CT images and PET images 
from LysMcreTNFfl/fl and TNFfl/fl mice with [18]F-FDG injected at 24 hours after pMCAO. Arrows indicate the 
ischemic infarct. SUV, standard uptake value. All data are presented as mean ± SEM.
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6Scientific RepoRts | 6:29291 | DOI: 10.1038/srep29291
Ablation of myeloid TNF does not result in changes in peripheral myeloid cell numbers or infil-
trating immune cells after pMCAO. Based on our previous findings of increased leukocyte infiltration in 
conventional TNF−/− mice4 and decreased macrophage infiltration in mice only expressing the transmembrane 
form of TNF (mTNFΔ/Δ)5 one day after pMCAO as well as altered microglial activation following anti-TNF 
treatment3, we investigated possible changes in microglia and infiltrating leukocytes in the cortex of TNFfl/fl  
and LysMcreTNFfl/fl mice 6 and 24 hours after pMCAO by the use of flow cytometry (Fig. 6a–d and Suppl. Fig. 
4a,b). At 6 hours, we found the total number of CD11b+CD45lowLy6C+Ly6G− microglia to be significantly 
increased in LysMcreTNFfl/fl mice compared to TNFfl/fl mice (Fig. 6b), most likely a result of increased CD11b 
expression in LysMcreTNFfl/fl mice under naïve conditions as measured by MFI (Suppl. Fig. 1a). As expected, 
at 24 hours after pMCAO, the time of maximal cytokine production, in TNFfl/fl and LysMcreTNFfl/fl mice the 
percentage and number of CD11b+CD45dim microglia were decreased in the ipsilateral cortex as compared 
to the contralateral (Suppl. Fig. 4a,b). However, no differences in percentage and cell number were observed 
between the two genotypes (Fig. 6b and Suppl. Fig. 4a,b). At 6 hours after pMCAO, the numbers of infiltrat-
ing CD11b+CD45highLy6ChighLy6G- macrophages (Fig. 6c) and CD11b+CD45highLy6ChighLy6G+ granulocytes 
(Fig. 6d) were low and comparable between the two genotypes. By 24 hours, the percentage and number of infil-
trating macrophages and granulocytes were significantly increased in the ipsilateral cortex of LysMcreTNFfl/fl and 
TNFfl/fl mice compared to the contralateral cortex, however with no difference between the two groups (Fig. 6c,d 
and Suppl. Fig. 4b). The number and percentage of infiltrating CD45highCD3+ T cells were minimal and did not 
change in the ipsilateral cortex as compared to the contralateral in either TNFfl/fl or LysMcreTNFfl/fl mice, nor 
between the two groups (Suppl. Fig. 4b).
At 6 hours, we found that the total number of TNF+ microglia was significantly decreased in LysMcreTNFfl/fl 
mice as compared to TNFfl/fl mice (Fig. 6e) and demonstrated an approximately 56% ablation of TNF in microglia. 
At 6 hours, none of the few infiltrating macrophages were found to express TNF (Fig. 6f). At 24 hours, the number 
of TNF+ macrophages was significantly decreased in LysMcreTNFfl/fl compared to TNFfl/fl mice (Fig. 6f) where 
only 0.5% of all macrophages in LysMcreTNFfl/fl mice were TNF+ compared to 3% in TNFfl/fl mice. At no time 
point did granulocytes express TNF. This suggests that leukocyte recruitment into the infarct area is not affected 
by TNF ablation in myeloid cells 6 and 24 hours after pMCAO.
By 24 hours after pMCAO the percentage of all leukocyte populations in the blood and spleen were compa-
rable between LysMcreTNFfl/fl and TNFfl/fl mice (Suppl. Fig. 4d,e). In the bone marrow, CD11b+CD45+Gr1− and 
CD45+CD3+ populations were significantly increased in LysMcreTNFfl/fl mice compared to TNFfl/fl mice, with a 
higher number and percentage of all CD45+ cells in LysMcreTNFfl/fl mice compared to controls (Suppl. Fig. 4e).
Localization of TNF, TNF-R1 and TNF-R2 in human stroke brains. To address TNF signaling in the 
context of human stroke pathophysiology, we analyzed TNF, TNF-R1, and TNF-R2 expression in the post-mortem 
brain of two stroke cases (Suppl. Table 4 and Fig. 7a–o, shown for 1 post-mortem brain only). The infarcted area, 
identified by HE staining (Fig. 7a,b), was characterized by extensive tissue disruption and presence of cell infil-
trates immunopositive for CD45 and CD68 (Fig. 7d,e,g,h). Iba1+ cells, mostly with macrophage morphology, 
were also found in high numbers within the infarct (Fig. 7j,k). GFAP+ astrocytes formed a demarcated glial scar 
and were found to be almost absent within the infarct (Fig. 7m,n). TNF+ cells were located primarily within 
the infarct and at the border between infarct and intact tissue (Fig. 7c,f). On the contrary, TNF-R1+ (Fig. 7i) 
and TNF-R2+ (Fig. 7l,o) cells were found in the border zone only, with TNFR2+ cells accumulating in a dense 
layer surrounding the infarct. TNFR1+ cells were located at the border zone and further away in the peri-infarct 
tissue. We also assessed TNF expression in mouse tissue 24 hours after pMCAO and found high numbers of 
TNF+CD11b+ cells within the infarct and peri-infarct area (Fig. 7p–r), confirming previous findings in mice4. No 
TNF+ astrocytes were detected (not shown).
Discussion
Using LysMcreTNFfl/fl conditional KO mice with specific ablation of TNF in myeloid cells, including microglia, 
we demonstrate that microglial-derived TNF contributes to TNF-mediated protective effects in experimental 
stroke. We and others previously demonstrated that in the CNS acutely after focal cerebral ischemia TNF is pro-
duced by microglia, not neurons or astrocytes3,4,22,23. Using chimeric mice, we also showed that microglial-derived 
TNF is neuroprotective whereas macrophage-derived TNF plays no role in acute infarct maturation4. Therefore 
we can conclude that worsening of the stroke pathology in LysMcreTNFfl/fl mice is dependent on the lack of 
microglial-derived TNF.
Our findings on expression of TNF and its receptors in brain specimens from stroke patients are in line with 
previous reports (reviewed in2) and underscore this study’s translational relevance of TNF signaling in human 
stroke pathology, not only in experimental models.
TNFfl/fl LysMcreTNFfl/fl P value
Ki (normalized) 1.63 ± 0.09 2.24 ± 0.23 * P = 0.03
K1 (normalized) 0.46 ± 0.06 0.66 ± 0.05 * P = 0.03
k2 (normalized) 0.30 ± 0.05 0.53 ± 0.06 * P = 0.02
k3 (normalized) 1.23 ± 0.15 2.14 ± 0.26 * P = 0.02
Table 1.  Ki, influx rate for an irreversible model; K1, rate constant from blood to tissue; K2, efflux rate from 
tissue back into blood; K3, rate of binding. All values are normalized to the respectively contralateral rate 
constants, hence values are relative to contralateral values. Data are presented as mean ± SEM, student’s t test.
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We and others have shown that TNF−/− mice exhibit a behavioral phenotype associated with increased loco-
motor activity and altered anxiety-related behavior, in addition to impaired spatial learning and memory24,25, 
while mTNFΔ/Δ mice, expressing only mTNF, display a normal behavioral phenotype5. In this study we show 
that conditional ablation of myeloid TNF alone did not impair locomotor or neuromuscular function. This may 
depend on the relatively limited TNF ablation in microglia from LysMcreTNFfl/fl mice in naïve conditions, which 
may not be sufficient to induce a measurable phenotype, suggesting that constitutively expressed TNF in the brain 
of naïve LysMcreTNFfl/fl mice is sufficient for maintenance of cognitive functions under physiological conditions. 
Alternatively, it may be that other sources of TNF in naïve conditions are supporting normal cognitive and loco-
motor function.
Eventhough in LysMcreTNFfl/fl mutant mice the deletion efficiency is around 85–98% in mature macrophages 
and near 100% in granulocytes26, we observed that in naïve CD11b+ microglia deletion efficiency was only 
around 20% and that recombination also occured in approximately 5% of neurons. Neuronal expression was 
very low, and we consistently never observed increased TNF expression in neurons in this model of experi-
mental stroke22,23,27,28. Furthermore, microglia increase their expression of LysM in ischemic and inflammatory 
conditions, leading to more efficient gene ablation in LysMcre expressing mice17–19. Indeed, we first verified abla-
tion efficiency in LPS-stimulated microglia cultures from LysMcreTNFfl/fl and TNFfl/fl mice by showing a marked 
reduction in TNF release (93%) and then by flow cytometry 6 hours after pMCAO demonstating a 56% reduction 
in TNF+ microglia in the ischemic brain. On the contrary, release of TNF was not affected in vitro in astrocytes, 
further validating efficient and selective ablation of TNF from microglial cells.
When we tested the effect of myeloid TNF deletion in experimental stroke, we found LysMcreTNFfl/fl mice to 
have significantly increased FDG uptake acutely (> 3 hours) and larger infarct volumes at 24 hours and 5 days after 
pMCAO, supporting our previous findings that constitutively expressed or early induced, microglial-derived TNF 
is neuroprotective in experimental stroke4. When evaluating the spatiotemporal dynamics of FDG uptake during 
acute pMCAO in TNFfl/fl and LysMcreTNFfl/fl mice, we found early microglial-derived TNF to affect FDG uptake 
in the ischemic tissue after pMCAO. Though assumptions of a steady state system is hampered in the acute phase 
after pMCAO and care should be taken not to use the kinetic model data as absolute true numbers, the findings of 
hyper-FDG in the ispsilateral cortex compared with the contralateral cortex within the first 2 hours after pMCAO 
in both strains of mice are consistent with previous findings of increased accumulation of glucose around the 
ischemic border29,30. This may reflect increased anaerobic glycolysis during acute cerebral ischemia to compensate 
the loss of ATP29–31 or alteratively that lack of microglial-derived TNF alters ongoing signaling cascades in the 
ischemic brain10,11. The finding of increased FDG uptake in the ipsilateral hemisphere of LysMcreTNFfl/fl mice 
compared to TNFfl/fl mice during acute ischemia supports the findings of increased infarct volumes 24 hours and 
5 days after pMCAO and demonstrate that conditional ablation of TNF in microglia modifies neuronal sensitivity 
to ischemia. The fact that we in the present study were not able to differentiate between FDG uptake in infarct 
and peri-infarct areas is due to the limited resolution (1 mm) of the PET scanner as imaging spatial resolution is 
essential to delineate these areas30.
In some studies JNK/SAPK and p38 MAPK were shown to promote cell death, whereas ERK1/2 opposed cell 
death32,33. In the present study we found SAPK/JNK and p38 ratios not to be changed both under naïve conditions 
and 6 hours after pMCAO, whereas ERK1/2 ratios were significantly decreased in naïve LysMcreTNFfl/fl mice, 
with a tendency still present 6 hours after pMCAO. These findings suggest that ERK signal transduction is altered 
in LysMcreTNFfl/fl mice. TNF is known to activate all three MAPKs in neurons, with ERK1/2 activation mediated 
Figure 4. MAPK activation after pMCAO. (a–c) Quantification of ERK1/2 and p-ERK1/2 (a), JNK/SAPK and 
p-JNK/SAPK (b), p38 and p-p38 (c) protein expression in brain tissue of naïve TNFfl/fl and LysMcreTNFfl/fl  
mice and 6 hours after pMCAO. Data are normalized to transcription factor II B (TFIIB) or α -actin protein 
expression. * P ≤ 0.05; * * P ≤ 0.01. Abbreviations: L-TNFfl/fl, LysMcreTNFfl/fl; UL, unlesioned. Representative 
experiments are shown. Results, expressed as percentage of naïve TNFfl/fl mice, are mean ± SEM of three mice 
per group in 2–4 independent setups.
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via MEK1/234 and ERK1/2 activation is known to have a dominant-negative effect on the apoptotic signaling 
of death receptors, including TNF-R133. However, ERK1/2 activation has been shown to primarily mediate cell 
protection through TNF-R1-mediated NF-κ B activation33. We and others have previously shown that the neu-
roprotective effect of TNF is mediated at least in part via TNF-R1 (reviewed in2). Even though NF-κ B activation 
and translocation are comparable in TNF−/− and WT mice after pMCAO4, it is possible that ablation of micro-
glial TNF leads to a decrease in ERK1/2 ratios and altered NF-κ B activation, which ultimately results in lack of 
NF-κ B-induced neuroprotection in LysMcreTNFfl/fl mice. In support of this, Rousseau et al.35 showed that in vitro 
LPS stimulation of macrophages results in sequential activation of the TPL2-MKK1/MKK2-ERK1/2 pathway 
followed by secretion of TNF and that inhibition of this pathway resulted in loss of TNF production. Alternatively, 
we speculate that conditional ablation of TNF in microglia may have affected microglial expression of P2X7 recep-
tors, as previously shown36. ATP, released from damaged cells as a consequence of ischemia, has been shown to 
act on P2X7 receptors on microglia and thereby activate MAPK (ERK1/2, JNK and p38), which results in the 
release of neuroprotective TNF37. Thus the balance between ERK and the JNK and p38 MAPK pathways may play 
an important role in neuronal cell survival or death in response to focal cerebral ischemia.
As a consequence of ischemia, microglial numbers decrease in the ipsilateral hemisphere after experimen-
tal stroke whereas leukocyte infiltration increases at the same time4,38. Stroke is known to stimulate bone mar-
row production of myeloid cells, including monocytes and granulocytes, which are subsequently recruited to 
the brain38,39. Also T cell numbers in the bone marrow have been shown to increase after experimetal stroke39. 
We therefore investigated changes in myeloid cell populations in the bone marrow from LysMcreTNFfl/fl and 
TNFfl/fl mice after pMCAO. We found that numbers and percentages of CD11b+CD45+Gr1− monocytes and 
CD45+CD3+ T cells were significantly increased in LysMcreTNFfl/fl mice 24 hours after pMCAO suggest-
ing that ablation of mesodermally-derived TNF results in an increase in the number of newly produced, bone 
marrow-derived monocytes and T cells. The signals that trigger leukocyte mobilization from the bone marrow 
Figure 5. Inflammatory changes in LysMcreTNFfl/fl after pMCAO. (a) Multiplex analysis showing comparable 
TNF, IL-1β , IL-6, IL-5, and CXCL1 protein levels in naïve TNFfl/fl and LysMcreTNFfl/fl mice but significantly 
increased levels 24 hours after pMCAO (* P ≤ 0.05, * * P ≤ 0.01; * * * * P ≤ 0.0001). IFNγ , IL-2, IL-4, IL-10, and 
IL-12 did not change in naïve conditions or after pMCAO. (b) Multiplex analysis showing significanly increased 
TNF-R1 levels in naïve LysMcreTNFfl/fl compared to TNFfl/fl mice but comparable levels at 5 days after pMCAO 
(* P ≤ 0.05). (c) TNF-R2 levels were comparable in naïve conditions and 5 days after pMCAO. Results, expressed 
as mean ± SEM (n = 4–5/group, t-test).
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after stroke are unknown and may represent potential targets for future therapies40,41. The bone marrow indirectly 
receives central autonomic innervation involving forebrain areas such as the insular and piriform cortex42, areas 
which often are affected by ischemia. This may account for the increased mobilization of monocytes and T cells in 
LysMcreTNFfl/fl mice, which also display significantly increased infarcts. We and others have shown that following 
cerebral ischemia cellularity decreases in the spleen3,43,44, which can be attributed to increased apoptotic cell death 
of lymphocyte populations43. Therefore, it is possible that the increase in CD3+ T cells in LysMcreTNFfl/fl mice 
compared to TNFfl/fl mice can be due to decreased ischemia-induced apoptosis of spleen lymphocytes. On the 
other hand, early splenic responses after stroke involve increased production of pro-inflammatory mediators45. It 
is therefore possible that the pro-inflammatory enviroment is altered in such a way that less T cells are deployed 
into the blood.
We have previously shown that the number of infiltrating leukocytes is significantly increased in TNF−/− com-
pared to WT mice 24 hours after stroke4. Since CD11b expression levels, known to be involved in inflammation 
by regulating leukocyte adhesion and migration46, were increased in naïve microglia, we investigated whether 
myeloid-derived TNF affected leukocyte infiltration into the ischemic brain. We found that infiltration of mac-
rophages, granulocytes and T cells was not affected in LysMcreTNFfl/fl mice at this time point, nor at 6 hours 
after pMCAO. Anti-TNF therapies decrease the number of granulocytes infiltrating the ischemic infarct 24 hours 
after pMCAO3, an effect suggested to be mediated via the acute phase response in the liver47. Since TNF is not 
deleted from liver cells in LysMcreTNFfl/fl mice26, it is possible that signals mediating granulocyte influx into the 
brain are not altered in these mice. Suprisingly, macrophage infiltration was not affected in LysMcreTNFfl/fl mice, 
given that we previously demonstrated reduced infiltration of macrophages into the brain of mTNFΔ/Δ mice 
24 hours after pMCAO5. As monocytes/macrophages have been shown to infiltrate the ischemic brain relatively 
late after pMCAO48, it is possible that the time point investigated in the present study is not optimal for address-
ing the influx of macrophages. Nevertheless, we have previously shown, that only microglial-derived TNF, and 
not macrophage-derived TNF, plays a role in the neuroprotective effects of TNF after pMCAO4, which was also 
supported by this study where we found no TNF+ leukocytes 6 hours after pMCAO.
All together, the present study supports microglial-derived TNF as beneficial and neuroprotective in the acute 
phase after experimental stroke and as a strong modulator of the neuroinflammatory response at later time points 
after experimental ischemia.
Materials and Methods
Mice. MLys1cre/x TNFflox/flox (LysMcreTNFfl/fl) breeding couples, with a specific deletion of TNF in myeloid 
cells26, were transferred from the Russian Academy of Sciences, Moscow to the Biomedical Laboratory at the 
University of Southern Denmark where they were established as a colony. The extent of TNF gene deletion in 
Figure 6. Changes in microglia and leukocyte profiles after pMCAO. (a–f) Flow cytometric 
gating strategy (a) and analysis of the total number of CD11b+CD45dimLy6ClowLy6G− microglia (b), 
CD11b+CD45highLy6ChighLy6G− macrophages (c), CD11b+CD45highLy6ChighLy6G+ granulocytes (d) and TNF+ 
microglia (e) and TNF+ macrophages (f) in the cortex of TNFfl/fl and LysMcreTNFfl/fl mice 6 and 24 hours 
after pMCAO. * P ≤ 0.05; * * P ≤ 0.01; * * * P ≤ 0.001; * * * * P ≤ 0.0001. Results are expressed as mean ± SEM of 5 
animals/group, t-test.
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Figure 7. Characterization of TNF expression and localization in the brain of patients with stroke and mice 
with experimentally induced stroke. (a,b) Haematoxylin and eosin (HE) stain of a > 7-day old ischemic infarct 
placed in the left internal capsule of a stroke patient. (c) Diaminobenzidine (DAB) staining of TNF located 
within the infarct showing TNF labelling in cells morphologically resembling leukocytes/microglia. (d,e) DAB 
staining of CD45+ cells located within the infarct and peri-infarct. (f) High magnification of (c) showing TNF+ 
cells located within the infarct. (g,h) DAB staining of CD68+ cells located within the infarct and peri-infarct. 
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macrophages and neutrophils is almost complete (< 98%), with no deletion in liver and thymus26. Littermate 
TNFflox/flox (TNFfl/fl) mice, with normal TNF epxression26, were used as controls. In addition, MLys1cre/mice49 
were purchased from the Jackson Laboratory and transferred to the Miami Project to Cure Paralysis where they 
were crossed with Rosa26-loxp-Stop-loxp-tdTomato reporter mice (established colony)50 to generate LysMtdTomato 
mice51. All mice used in the present study were adult (7–10 weeks) males. All experimental protocols were 
approved by The Danish Veterinary and Food Administration (J. No. 2011/561–1950 and 2013-15-2934-00924) 
and according to the University of Miami IACUC and NIH guidelines. All efforts were made to minimize pain 
and distress and the methods were carried out in accordance with the relevant guidelines.
Genotyping. TNFfl/fl mice were genotyped by a two-oligonucleotide primer PCR assay and Cre-mediated 
recombination and completion of deletion were established using a three-oligonucleotide primer PCR assay26. 
Primer sequences were: KO41 (5′ -TGAGTCTGTCTTAACTAACC) and KO42 (5′ -CCCTTCATTCTCAAGGCACA) 
for TNF and a combination of primers Cre8 (CCCAGAAATGCCAGATTACG), Mlys1 (CTTGGGCTGCCA 
GAATTTCTC) and Mlys2 (TTACAGTCGGCCAGGCTGAC) for Cre.
Cerebrovascular anatomy. The circle of Willis and its branches were examined in LysMcreTNFfl/fl and 
TNFfl/fl mice essentially as previously described4 using a Toluidine blue (TB) solution. Vessels were photographed 
under a dissecting microscope and the left an right posterior communicating (PCOM) arteries scored as follows: 0, 
absent; 1, present, but poorly developed (hypoplastic); 2, well formed. A single PCOM score was obtained by 
averaging left and right scores.
Body Composition Measurements. Total tissue mass (g), fat mass (g), fat-%, lean tissue mass (g), lean-%, 
bone area (cm2), bone mineral content (BMC, g/cm) and bone mineral density (BMD, g/cm2) were measured in 
naïve LysMcreTNFfl/fl and TNFfl/fl using dual-energy X-ray absorptiometry (DXA) using a PIXImus2 (Version 
1.44; Lunar Corporation, Madision, WI, USA) as previously described5,52.
Induction of focal cerebral ischemia. The distal part of the left middle cerebral artery was permanently 
occluded (pMCAO) under Hypnorm/Stesolid anesthesia [Fentanyl Citrate (0.315 mg/mL; Jansen-Cilag) and 
Fluanisone (10 mg/mL; Jansen-Cilag); and Diazepamum (5 mg/mL; Dumex)]22,28. After surgery, mice were sup-
plied with 0.9% saline and maintained in a 28 °C controlled environment. Mice with 5 days survival were housed 
in the behavioral room in the conventional animal facility after 24 hours. For post-surgical analgesia, mice were 
treated with Temgesic (0.001 mg/20 g body weight buprenorphium; Reckitt and Colman) three times at 8 hours 
intervals starting prior to surgery.
Positron emission tomography (PET) analysis. Micro PET imaging was performed on a Siemens 
Inveon PET scanner. The animals were scanned twice. The first scan was performed in the acute phase, 1–2 hours 
after surgery, and the second scan 24 hours later. Animals were placed in prone position on a heated scanner bed 
and injected with 18[F]-FDG via a tail vein catheter. The animals were anesthetized throughout the entire imaging 
procedure using a mixture of 1.5–2% isoflurane and 100% oxygen.
At day 0 (1–2 hours after pMCAo) 10.9 ± 2.4 MBq 18[F]-FDG was injected and data was acquired for 90 min. 
Data was binned in 20 frames (4 × 30 s + 10 × 1 min + 1 × 3 min + 5 × 15 min), beginning with short frames to 
capture the fast vascular phase moving to a slower frame rate appropriate for the dynamics beyond 15 min. At 
day 1 (24 hours after pMCAo) 10.7 ± 1.2 MBq 18[F]-FDG was injected. After a 30 min delay a 15 min static image 
was acquired.
All images were reconstructed using OSEM3D/MAP matrix 128 × 128, 4 OSEM3D iterations and 18 MAP 
iterations with requested resolution of 0.8 mm. A zoom factor of 2 was applied yielding a voxel size of approxi-
mately 0.4 mm × 0.4 mm in the XY-plane and a slice thickness of 0.8 mm. The reconstruction was carried out with 
the build in algorithm of Siemens Inveon Acquisition Workplace software version 1.5.
A computer tomography (CT) image of a single animal was acquired and used as an anatomical reference. All 
images were analyzed and the kinetic modeling done within the Siemens Inveon Research Workplace software 
version 4.2. The reference CT and the PET images were manually co-registered. The images acquired at day 0 
were analyzed using a 2-tissue-compartment irreversible FDG model. Image derived blood input functions53 
were used to calculate the 3 rate constants K1 (transport rate constant from blood to brain tissue), k2 (rate con-
stant from brain tissue back to blood), k3 (binding in the cells (phosphorylation))31. The FDG uptake (influx) rate 
constant Ki was calculated as Ki = K1k3/(k2 + k3). The glucose uptake (metabolism) is proportional to Ki, glucose 
(i) DAB staining of TNFR1+ cell located in the peri-infarct area. (j,k) DAB staining of Iba1+ microglia and 
leukocytes located within the infarct and in the peri-infarct. (l) DAB staining of TNFR2 located in the peri-
infarct area showing TNFR2 labelling in cells with a glial morphology. (m,n) DAB staining of GFAP+ astrocytes 
located in the peri-infarct. (o) High magnification of (l) showing TNFR2+ cells in the peri-infarct. (p) Alkaline 
phosphatase (AP) staining of TNF located within a 24-hours old infarct and in the peri-infarct placed in the 
parietal cortex of a mouse showing TNF labelling in cells morphologically resembling leukocytes/microglia. 
(q) Double-immunofluorescent labelling of TNF with CD11b, demonstrating TNF expression in microglia/
leukocytes. (r) High power magnification photomicrographs of double-fluorescent labelling of TNF with 
CD11b showing TNF in vesicles located both in the cytoplasm surrounding the nucleus and in the processes 
extending from the cells. Scale bars: (a,d,g,j,m) = 400 μ m, (b,c,e,h,i,k,l,n) = 100 μ m, (f,o) = 30 μ m, (p,q) = 200 μ m, 
(r) = 20 μ m. Abbreviations: IF, infarct.
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uptake = Ki (blood glucose/LC), where LC is the lumped constant. The FDG uptake is a very sensitive measure 
and is influenced by many factors including dietary condition (insulin level), ambient temperature and mode 
of anesthesia54. In order to overcome some of these limitations, we used the animals as their own reference and 
calculated the rate constants from the ipsilateral volume of interest (VOI) normalized to contralateral reference 
rate constants. Curves are presented as standardized uptake values (SUV = tissue activity concentration (Bq/mL) 
x Animal weight (g)/injected activity (Bq)).
Volumes of interest were semi-automatically made by first drawing a volume covering the increased FDG 
uptake in the ipsilateral region. The final VOI was calculated by setting a threshold of 70% of maximum within 
the last image of the dynamic series. This VOI was mirrored onto the contralateral brain hemisphere as a refer-
ence VOI for the unaffected brain tissue. The blood input VOI was manually created in the first or second frame 
where the vena cava was clearly visualized. The blood input VOI was manually drawn as the part of vena cava 
with highest activity.
Behavioral Tests. Open field test. Locomotor activity was investigated using the open field test in a group 
of naïve LysMcreTNFfl/fl and TNFfl/fl mice as previously described52 in order to detect potential phenotypic differ-
ences in locomotor- and anxiety-related activities. In addition, locomotor activity was investigated 2 days after 
pMCAO in order to test for changes in behavior induced by the ischemic brain lesion. The total distance traveled 
(cm), speed (V(mean), cm/sec), center/perimeter ratio, and entries into the three zones (wall, inter peri and 
center of the box) were recorded automatically for 10 min. Rearing, time to first rear, grooming and droppings 
were recorded manually and are given as number of events (n).
Y-maze spontaneous alternation test. In order to test spatial leaning and memory in naïve LysMcreTNFfl/fl and 
TNFfl/fl the spontaneous alternation test was performed using a Y-maze as previously described52. Each mouse 
was placed in the arm designated (A) of the Y-maze and allowed to freely explore the maze for 8 min. The number 
of entries, except for the first two, and the number of triads were recorded and the percentage of alternation was 
calculated.
Rotarod test. In order to evaluate motor coordination/performance and balance52, the rotarod test (LE8200, 
Panlab Harvard Apparatus) was performed. The test comprised a pre-training part prior to surgery (30 sec at 4 
rotations per min (rpm)) and a trial part consisting of 4 trials (T1 – T4, with at least 15 min in-between) 5 days 
after surgery. Mice were placed on the rotarod set in accelerating mode. Speed of the rotor was accelerated from 4 
to 40 rpm over 5 min. Total time spent on the rotarod for each mouse was measured.
Rung walk test. In order to test stepping, inter-limb coordination and balance, the rung walk test was performed 
2 days after pMCAO as previously described6,55. The total number of mistakes on each front and hind paw was 
plotted for analysis of asymmetry. Prior to surgery, mice were pre-trained in the rung walk test and no asymmetry 
was observed under baseline conditions (data not shown).
Grip strength test. The grip strength measuring device (BIO-GT-3, BIOSEB) was used to study neuromuscular 
function in mice subjected to pMCAO. The peak amount of force was recorded in 5 sequential trials and the 
highest grip value was recorded as the score4. We analyzed the grip strength in individual (left and right) front 
paws prior to (baseline) and 3 and 5 days after pMCAO. The unit of force measured is presented as grams (g). 
Asymmetry between paws in individual mice following pMCAO was calculated and is presented as delta (Δ ) grip 
strength5.
Tissue processing. Fresh frozen tissue. Mice were killed by cervical dislocation, and brains quickly 
removed, frozen in CO2 and cut coronally in six parallel series of 30 μ m and stored at − 80 °C until further pro-
cessing5. Blood samples were collected in EDTA-coated Eppendorf tubes, spun 2 × 10 min at 3,000 g, 4 °C, and 
plasma stored at − 80 °C until further processing.
Paraformaldehyde (PFA) fixed tissue. LysMtdTomato mice were anesthetized with Ketamine/Xylazine 
(100 mg/10 mg/kg) and transcardially perfused with 4% PFA. For cell counting, tissue was processed as previously 
described51, and brains were cut into 20 μ m-thick, sagittal cryostat sections and stored at − 20 °C until further 
processing. For cortical volume estimations, LysMcreTNFfl/fl and TNFfl/fl mice were overdosed using Pentobarbital 
(200 mg/ml)/Lidocainhydrochlorid (20 mg/ml) and transcardially perfused with 4% PFA. Brains were fixed in 
4% PFA overnight, changed to 1% PFA and finally 0.1% PFA before they were horizontally vibratome-cut into six 
60 μ m-thick parallel series of free floating sections and cryoprotected in de Olmo’s solution5. For immunofluo-
rescent staining, brains were cryoprotected in 20% sucrose overnight, frozen in CO2 snow and cut into 10 series 
of parallel 20 μ m-thick coronal sections on a cryostat. Sections were stored at − 20 °C until further processing.
Volume estimations. Infarct volume. Every sixth section (1 series) from mice with 24 hours and 5 days 
survival after pMCAO was stained with TB for estimation of infarct volume using the Cavalieri principle28,56. The 
rostrocaudal distribution of the infarct was analyzed as previously described5 using the anterior commisure as an 
antomical landmark.
Neocortical volume. The volume of the neocortex was estimated in naïve TNFfl/fl and LysMcreTNFfl/fl mice using 
Cavalieri’s principle as previously decribed in detail5.
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Immunostaining. Immunohistochemistry. In fresh-frozen sections, TNF was detected using a rabbit 
anti-TNF antibody (clone R4-6A2, 1:200, Pierce Antibody Products) and AP-conjugated anti-rabbit antibody 
as previously described27. Primary microglia and primary astrocytes were stained for microglial CD11b (clone 
M1/70.15, 1:600, Abdserotec) and astroglial GFAP (1:4,000, Dako) in order to evaluate the purity of the cultures. 
Substitution of the primary antibody with rabbit IgG (DakoCytomation) or IgG1 gave no signal.
Immunofluorescent staining. Immunofluorescent staining for TNF co-locatization was performed essentially 
as described in Clausen et al.57 using rabbit anti-TNF, rat anti-CD11b and mouse anti-human GFAP-Alexa 
Fluor-488 (clone 131-17719, 1:400, Life Technologies) antibodies. Donkey anti-rabbit Alexa Fluor-594 and goat 
anti-rat Alexa Fluor-488 antibodies (1:200, Invitrogen) were used as secondary antibodies. Rabbit IgG was used 
as a serum control, rat IgG2b (IG-851125, Biosite) and mouse IgG-488 (Invitrogen) were used as isotype con-
trols. Substitution of the primary antibody with isotype control or rabbit IgG gave no signal. Digital images 
were captured using an Olympus BX51 microscope connected to a PC containing DP manager software (version 
2.1.1.158). Figures were composed using Photoshop CS5 software.
LysMcre co-localization in the adult brain was investigated using rat anti-CD11b (clone M1/70.15, 1:500, 
Invitrogen), rat anti-GFAP (clone 2.2B10, 1:2,000, Invitrogen), mouse anti-NeuN (clone A60, 1:200, Millipore), 
rabbit anti-red fluorescent protein (RFP) (1:4,000, Rockland), and rabbit anti-Olig2 (1:200, Millipore). Donkey 
anti-mouse Alexa Fluor-488, donkey anti-rat Alexa Fluor-488, donkey anti-rabbit Alexa Fluor-488, and goat 
anti-rabbit Alexa Fluor-568 (1:500) were used as secondary antibodies. DAPI (4’,6-diamidino-2-phenylindole) 
was used as a nuclear marker. Sections were coverslipped using Vectashield (Vectorlabs). Digital images of the 
cortex were captured using a Nikon Eclipse Ti epifluorescent microscope with NIS Elements software.
Estimation of cell numbers. Cell counting. Quantification of LysM+ cells was based on co-localization 
of the tdTomato reporter signal, which was enhanced using a RFP antibody with the various cell identification 
markers (NeuN, CD11b, and GFAP). Co-localization with oligodendroglial Olig2 was performed with the endog-
enous tdTomato signal. In total, 151–171 LysM+ (tdTomato) cells spread across at least three non-consecutive 
tissue sections were counted per animal (n = 3). All cells had a clearly identifiable DAPI+ nucleus.
Primary microglia and astrocyte cultures. For preparation of primary microglia and astrocyte cultures, 
0–2 day old LysMcreTNFfl/fl and TNFfl/fl pups were decapitated, the brains isolated, and the meninges removed. 
Tail biopsies were obtained for genotyping. Brains were then placed in pre-warmed DMEM-GlutaMAX cul-
ture media (Gibco) containing 20% FCS and 1% penicillin/streptomycin (Gibco), mechanically homogenized by 
pipetting and filtered through a 70 μ m cell strainer (Falcon). Cells corresponding to the number obtained from 1 
brain were seeded into poly L-ornithine pre-coated 24-well culture dishes (Costar) and grown at 36 °C (20% O2 
and 5% CO2) for up to 21 days. Fifty percent of the culture medium was changed every 3–4 days. After 7 days, the 
medium was changed to culture medium containing 10% FCS and 1% penicillin/streptomycin and cells grown for 
an additional 7 days. After 14 days in vitro, microglia were removed from the layer of confluent astrocytes by gen-
tly shaking at 100 rpm for 2 hours at room temperatur. Microglia were harvested from the same dish twice with 7 
days intervals. Microglia and astrocytes were separated and centrifuged separately at 1,000× g for 5 min at room 
temperature. The supernatant was removed and cells resuspended in medium before plated into 24-well plates 
(20,000 cells/well). Microglia were then stimulated with 10 ng/mL lipopolysaccharide (LPS) (from Escherichia 
coli 0111:B4, Sigma) and astrocytes with either 10 ng/ml recombinant TNF (Sigma) or 10 ng/ml recombinant 
interleukin (IL)-1β (Sigma) for 24 hours. Unstimulated cultures were used as controls. After 24 hours, the media 
was removed and stored at − 80 °C until further analysis. Cells were then prepared for immunohistochemistry 
by 3 x rinses in 0.15 M Sorensen Buffer (SB), fixation for 20 min i 4% PFA, 3 x rinses in 0.15 M SB and stored in 
0.15 M SB for evaluation of purity (described above), which was found to be > 95% (data not shown).
ELISA for TNF. The amount of TNF present in the media from LPS-stimulated and unstimulated micro-
glia and TNF- or IL-1β -stimulated or unstimulated astrocyte cultures was examined using the Mouse TNF 
ELISA MAXTM Deluxe Sets (Biolegend) according to the manufacturer’s instructions. The obtained data was 
processed and analyzed by the interface software program SoftMax®Pro. Each standard and test was determined 
in duplicate.
Flow cytometry. Cre expression in the cortex of LysMtdTomato mice. For flow cytometry, cells from 
LysMtdTomato mice were isolated as previously described58, with minor modifications. Briefly, after transcardial 
perfusion with PBS, cortices were dissected out and placed in cold Hanks’ Balanced Salt Solution (HBSS). Tissues 
were enzymatically dissociated using the neural tissue dissociation kit containing papain (Miltenyi Biotec) and 
washed in cold HBSS. Suspensions were cleared from myelin by incubation with Myelin Removal Beads II fol-
lowed by negative selection with LS columns (Miltenyi Biotech), according to manufacturer’s instructions. Cells 
were washed in FACS buffer (eBioscience), blocked with anti-CD16/32 (FcR block, eBioscience) to prevent 
non-specific staining, and stained with FITC-anti-CD45 (1:200, eBioscience) and PE-Cy7-anti-CD11b (1:200, 
eBioscience). Cell suspensions were fixed in 1% PFA and resuspended in FACS buffer. Samples were analyzed 
with an LSRII flow cytometer (BD Biosciences) equipped with FACS-Diva 6.0 software (BD Biosciences).
Cell population analysis in TNFfl/fl and LysMcreTNFfl/fl mice. Flow cytometry was performed as previ-
ously described using the FACSVerse (BD Biosciences) and data analyzed using the FACSuite software3,5. 
Microglia [CD11b+CD45dim or CD11b+CD45dimLy6ClowLy6G−], macrophages [CD11b+CD45highGr1− or 
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CD11b+CD45highLy6ChighLy6G−], granulocytes [CD11b+CD45highGr1+ or CD11b+CD45highLy6C+Ly6G+], T 
cells [CD45highCD3+], TNF+ microglia and TNF+ macrophages were identified as previously described3,5.
Prior to fixation, cells were stained for live/dead cells using a Fixable Viability Dye eFluoro 506 (eBiosci-
ence) diluted in PBS5. For TNF expression analysis, cell suspensions were incubated for 4 to 6 hours in vitro 
with the protein transport inhibitor GolgiPlug (BD Biosciences) and processed as previously described3,4. A total 
of 1,000,000 events were collected using FSC and SSC and analysis of the live/dead gate revealed comparable 
numbers of dead cells in all the samples. Furthermore, blood and spleen samples, in addition to bone marrow at 
24 hours after pMCAO, were collected and analyzed for CD45, CD11b, Gr1, and CD3 markers.
Positive staining was determined based on fluorescence levels of the respective isotype and fluorescence 
minus one (FMO) controls. Antibodies were directly conjugated with fluorochromes: PerCP Cy5.5 anti-CD45 
(BD Biosciences, clone 30-F11), PE anti-CD11b (BD Biosciences, clone M1/70), PE-Cy7 anti-Ly6G/Ly6C 
(Gr1) (Biolegend, clone RB6-8C5), PE-Cy7 anti-Ly6C (BD Biosciences, clone AL-21), BV421 anti-Ly6G (BD 
Biosciences, clone 1A8), APC anti-TNF (Biolegend, clone MP6-XT22), and APC anti-CD3 (BD Biosciences, 
clone 145-2C11). Isotype controls used were hamster IgG1κ (BD Biosciences, clone A19-3), rat IgG2b (BD 
Biosciences, clone A95-1 or Biolegend, clone RTK4530), rat IgG1κ (Biolegend, clone RTK2071), rat IgMκ (BD 
Biosciences, clone R4-22), Lewis IgG2aκ (BD Biosciences, clone R35-95), and mouse IgG1 (BD Biosciences, clone 
MOPC-21). The mean fluorescence intensity (MFI) was calculated as the geometric mean of each population in 
the TNF, CD45 and CD11b positive gates, respectively3.
Multiplex and Western blotting analyses. Protein purification. One series of brain tissue was lysed in 
1x Tris Lysis buffer (150 nM NaCl, 20 mM Tris, 1 mM EDTA, 1 mM EGTA, 1% Triton-x100, pH 7.5) containing 
phosphatase inhibitor (Sigma) and cOmplete mini, EDTA-free proteinase inhibitor cocktail (Roche). Protein 
estimations were performed using the Bradford method.
Multiplex analysis. Plasma and brain samples were measured in the MSD Mouse Proinflammatory V-Plex Plus 
Kit (IFNγ , IL-1β , IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, CXCL1, TNF; K15012C, Mesoscale) and in brain samples 
the mouse TNF-RI and TNF-RII Ultra-Sensitive Kits (Mesoscale) using a MSD QuickPlex (SQ120) Plate Reader 
(Mesoscale) according to the manufacturer’s instructions5. Samples were run in duplex and diluted 2- or 4-fold in 
Diluent 41 prior to measurement. Data was analyzed using MSD Discovery Workbench software. The lower limit 
of detection was a calculated concentration based on a signal 2.5 SD above the blank (zero) calibrator.
Western blot analysis. Western blot analysis for TNF (1:2,000, Abcam) was performed using 20 μ g protein 
extract separated on 4–12% SDS-PAGE gels (Nupage, Invitrogen) essentially as previously described3,4. As a 
positive control, 0.5 ng 17 kDa murine recombinant TNF (Sigma Aldrich) was included. Western blotting anal-
ysis for SAPK/JNK (Cell Signaling, 1:1,000), phosphorylated (p)-SAPK/JNK (Thr183/Tyr185) (Cell Signaling, 
1:1,000), p44/p42 MAPK (Cell Signaling, 1:1,000), p-p44/p-p42 MAPK (ERK1/2)(Cell Signaling, 1:1,000), p-38 
(Cell Signaling, 1:1,000), p-p38 MAPK (Tyr180/Tyr182)(Cell Signaling, 1:1,000), and Iba1 (Wako, 1:500) was per-
formed by resolving equal amounts of protein lysates by SDS-PAGE on NuPage Bis 4–12% gels, using MOPS SDS 
(Invitrogen) containing 0.25% antioxidant (Invitrogen) essentially as previously described6,59. TFIIB (1:1,000, Cell 
Signaling), GAPDH (1:2,500, Abcam) and α -actin (1:8,000, Millipore) were used as loading controls. SeeBlue 
Plus2 prestained standard (Invitrogen) was used as a molecular weight marker. Bands were quantified with 
Quantity One software (Biorad). Analysis was performed on 2–4 independent gels with n = 2–3/group and data 
were normalized to TFIIB, GAPDH or α -actin and represented as percentages relative to naïve TNFfl/fl mice or 
as ratios (for MAPK).
Human stroke tissue. The study was performed on post mortem brain tissue from two stroke cases obtained 
from the Department of Pathology, Odense University Hospital and the use of human brains was approved by 
the Danish Biomedical Research Ethical committee for the Region of Southern Denmark (permission number 
S-20080042). Sex, age, infarcted brain area and age of infarct are given in Suppl. Table 4. Specimens from these 
brains have been part of a previous study on surfactant protein-D in human ischemic brain tissue60.
Immunohistochemistry in human stroke tissue. Tissue blocks containing infarcted human brain tis-
sue were imbedded in paraffin and 2 μ m thick, serial sections were cut on a microtome, deparaffinized, blocked 
in 1.5% H2O2 in Tris-buffered saline (TBS) and demasked in T-EG buffer (10 mM Tris + 0.5 mM EGTA, pH 9.0), 
whereafter they were loaded onto a Dako autostainer (Dako, Denmark)61. Sections were stained using the following 
primary antibodies: rabbit anti-Iba1 (ionized calcium binding adaptor molecule 1, 1:1,000, Wako), mouse anti-CD45 
(1:200, Dako), mouse anti-CD68 (1:100, Dako), rabbit anti-GFAP (glial fibrillary acidic protein, 1:2,000, Dako), rab-
bit anti-TNF (1:100, Endogen)4,23,27, rabbit anti-TNFR1 (1:50 (H-271), Santa Cruz), and rabbit anti-TNFR2 (1:50, 
Sigma-Aldrich). Secondary antibodies included EnVision + System horseradish peroxidase (HRP)-labelled Polymer 
(Dako) for CD45, CD68 and GFAP, Advance HRP (Dako) for TNF and TNFR1, and PowerVision + Poly-HRP IHC 
detection system (AH Diagnostics) for TNFR2. Omission of primary antibody and comparable concentrations of 
rabbit IgG were used to control for unspecific binding in the immunohistochemical protocols for TNF, TNFR1 and 
TNFR2 and these sections were devoid of staining. In addition, parallel sections were stained for hematoxylin and 
eosin (HE) using standard protocols at the Department of Pathology, Odense University Hospital.
Statistics. For multiple comparisons, one-way or two-way ANOVA was applied. When appropriate, repeated 
measures were used. Each test was followed by the relevant post-hoc test. For single comparisons unpaired and 
paired student’s t-tests were applied. P values ≤ 0.05 were considered statistically significant. Data are presented 
as mean ± SEM.
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